Astellas Pharma(JP:4503)
¥2,725.00-5.00 (-0.18%)
JP:4503
Astellas Pharma earnings date
¥2,725.00
At close:-5.00 (-0.18%)
Want to see JP:4503 full AI Analyst Report?
Astellas Pharma (4503) Q2 2025 Earnings Report
5 Followers
JP:4503 Q2 2025 EPS Results
- Actual EPS
- JPY 44.22
- Consensus EPS
- JPY 29.81
- Beat/Miss
- Beat by +JPY 14.41
- One Year Ago EPS
- JPY 20.06
JP:4503 Q2 2025 Revenue Results
- Actual Revenue
- JPY 524.32B
- Expected Revenue
- JPY 481.09B
- Beat/Miss
- Beat by +JPY 43.23B
- YoY Revenue Growth
- +13.37%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 10/30/2025
- Time
- Before Open
- Conference Call
- Thursday, October 30, 2025
JP:4503 Upcoming Earnings
Astellas Pharma's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
JP:4503 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4503 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2026 (Q3) | 59.98- | 56.04 | ― | ― |
| Nov 04, 2026 | 2026 (Q2) | 65.0255.68 | 44.22 | 25.92% (+11.46) | |
| Aug 05, 2026 | 2026 (Q1) | 54.1079.15 | 38.22 | 107.09% (+40.93) | |
| Apr 27, 2026 | 2025 (Q4) | 30.5824.29 | 41.84 | -41.95% (-17.55) | |
| Feb 04, 2026 | 2025 (Q3) | 45.9356.04 | -54.55 | 202.73% (+110.59) | |
| Oct 30, 2025 | 2025 (Q2) | 29.8144.22 | 20.06 | 120.44% (+24.16) | |
| Jul 30, 2025 | 2025 (Q1) | 19.8738.22 | 21 | 82.00% (+17.22) | |
| Apr 25, 2025 | 2024 (Q4) | 21.3241.84 | -18.55 | 325.50% (+60.39) | |
| Feb 04, 2025 | 2024 (Q3) | 24.52-54.55 | 10.4 | -624.52% (-64.95) | |
| Oct 30, 2024 | 2024 (Q2) | 18.0120.06 | -0.8 | 2607.50% (+20.86) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


